ECSP045455A - N-ACILAMINOBENCENO DERIVATIVES AS SELECTIVE INHIBITORS OF MONOAMINO OXIDASA B - Google Patents

N-ACILAMINOBENCENO DERIVATIVES AS SELECTIVE INHIBITORS OF MONOAMINO OXIDASA B

Info

Publication number
ECSP045455A
ECSP045455A ECSP045455A ECSP045455A EC SP045455 A ECSP045455 A EC SP045455A EC SP045455 A ECSP045455 A EC SP045455A EC SP045455 A ECSP045455 A EC SP045455A
Authority
EC
Ecuador
Prior art keywords
carbon atoms
alkyl
hydrogen
alkoxy
halogen
Prior art date
Application number
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP045455 priority Critical patent/ECSP045455A/en
Publication of ECSP045455A publication Critical patent/ECSP045455A/en

Links

Abstract

Esta invención se refiere a derivados N-acilamino arilo de fórmula general en donde R1 es halógeno, -alquilo de 1 a 6 átomos de carbono, ciano, alcoxilo de 1 a 6 átomos de carbono ó halógeno-alcoxilo de 1 a 6 átomos de carbono; R21,R22,R23 y R24 independientemente entre sí se seleccionan del grupo formado por hidrógeno, alquilo de 1 a 6 átomos de carbono, halógeno, -alquilo de 1 a 6 átomos de carbono, hidroxilo, alcoxilo de 1 a 6 átomos de carbono ó -CHO;R3 es hidrógeno o alquilo de 1 a 3 átomos de carbono;R4, R5 independientemente entre sí, se seleccionan del grupo formado por hidrógeno, alquilo de 1 a 6 átomos de carbono, alcoxilo de 1 a 6 átomos de carbono ó -COO(alquilo de 1 a 6 átomos de carbono); ó R4 y R5 forman juntamente con el átomo de C al cual están unidos un anillo cicloalquilo de 3 a 7 átomos de carbono;R6 es -CO-NR7R8; -COO(alquilo de 1 a 6 átomos de carbono), -CN, -NR2 ó -NHC(O)R;R7 y R8 independientemente entre sí, se seleccionan del grupo formado por hidrógeno, alquilo de 1 a 6 átomos de carbono, NH2 ó hidroxilo;R es hidrógeno o alquilo de 1 a 6 átomos de carbono;n es 0, 1, 2 ó 3.X es -CHRO, -OCHR-, -CH2S-, -SCH2-, -CH2CH2-, -CH=CH- ó -CºC-; y a las sales de adición ácida farmacéuticamente activas de los mismos. Se ha descubierto que los compuestos de fórmula general I son inhibidores selectivos de la monoamino oxidasa, y son por lo tanto de utilidad en el tratamiento de enfermedades mediadas por los inhibidores de la monoamino oxidasa B, por ejemplo, para el tratamiento de la enfermedad de Alzheimer o la demencia senil.This invention relates to N-acylamino aryl derivatives of the general formula wherein R 1 is halogen, -alkyl of 1 to 6 carbon atoms, cyano, alkoxy of 1 to 6 carbon atoms or halogen-alkoxy of 1 to 6 carbon atoms ; R21, R22, R23 and R24 independently from each other are selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, halogen, -alkyl of 1 to 6 carbon atoms, hydroxyl, alkoxy of 1 to 6 carbon atoms or -CHO; R3 is hydrogen or alkyl of 1 to 3 carbon atoms; R4, R5 independently of each other, are selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms or - COO (alkyl of 1 to 6 carbon atoms); or R4 and R5 together with the C atom to which a cycloalkyl ring of 3 to 7 carbon atoms is attached: R6 is -CO-NR7R8; -COO (alkyl of 1 to 6 carbon atoms), -CN, -NR2 or -NHC (O) R; R7 and R8 independently of each other, are selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, NH2 or hydroxyl; R is hydrogen or alkyl of 1 to 6 carbon atoms; n is 0, 1, 2 or 3.X is -CHRO, -OCHR-, -CH2S-, -SCH2-, -CH2CH2-, -CH = CH- or -C ° C; and to the pharmaceutically active acid addition salts thereof. It has been found that the compounds of general formula I are selective inhibitors of monoamine oxidase, and are therefore useful in the treatment of diseases mediated by monoamine oxidase B inhibitors, for example, for the treatment of the disease of Alzheimer's or senile dementia.

ECSP045455 2004-11-26 2004-11-26 N-ACILAMINOBENCENO DERIVATIVES AS SELECTIVE INHIBITORS OF MONOAMINO OXIDASA B ECSP045455A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP045455 ECSP045455A (en) 2004-11-26 2004-11-26 N-ACILAMINOBENCENO DERIVATIVES AS SELECTIVE INHIBITORS OF MONOAMINO OXIDASA B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP045455 ECSP045455A (en) 2004-11-26 2004-11-26 N-ACILAMINOBENCENO DERIVATIVES AS SELECTIVE INHIBITORS OF MONOAMINO OXIDASA B

Publications (1)

Publication Number Publication Date
ECSP045455A true ECSP045455A (en) 2005-01-28

Family

ID=40419316

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP045455 ECSP045455A (en) 2004-11-26 2004-11-26 N-ACILAMINOBENCENO DERIVATIVES AS SELECTIVE INHIBITORS OF MONOAMINO OXIDASA B

Country Status (1)

Country Link
EC (1) ECSP045455A (en)

Similar Documents

Publication Publication Date Title
AR040133A1 (en) DERIVATIVES OF N-ACILAMINO BENCIL ETER
AR062056A1 (en) FUSIONED HETEROCICLIC DERIVATIVES AND METHODS OF USE
AR040489A1 (en) COMPOUNDS DERIVED FROM 3-PHENYL-PROPIONAMIDE, 3-PHENYL-ACRYLAMIDE AND 3-PHENYL-PROPINAMID, ITS USE FOR THE PREPARATION OF MEDICINES, A PROCESS TO PREPARE THE COMPOUNDS AND MEDICINES CONTAINING THEM
AR076550A1 (en) INHIBITORS OF THE JANUS TIROSINA KINASA (JAK)
SG166019A1 (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
NO20082934L (en) Antiviral nucleotides
AR041297A1 (en) DERIVATIVES OF 4-PIRROLIDINO- FENIL- BENCIL ETER
ATE544744T1 (en) METHOD FOR PRODUCING BENZOIC ACID DERIVATIVES
EA200800285A1 (en) NEW DERIVATIVES 2,4-DIANILINOPIRIMIDINES, THEIR PRODUCTION, MEDICINES, PHARMACEUTICAL COMPOSITIONS, CONTAINING INDICATED DERIVATIVES, AND THEIR APPLICATION, IN PARTICULAR, AS THE PROTECTIVE.
NO20076006L (en) acetylene Derivatives
GT200600134A (en) NEW COMPOUNDS OF AMINOSULPHONYL DERIVATIVES
UY28135A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
ATE556058T1 (en) 1-(2H)-ISOCHINOLOONE DERIVATIVE
CO5700824A2 (en) NEW USEFUL HETEROCICLIC COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TW200612920A (en) Novel imidazolidine derivatives
AR079250A1 (en) DERIVATIVES OF PIRAZOLO [1,5-A] USED PIRIDINE IN THE TREATMENT OF CNS AND CANCER DISEASES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND SYNTHESIS INTERMEDIARY.
ECSP088084A (en) DERIVATIVES OF N- (HETEROARIL) -1-HETEROARILALQUIL-1H-INDOL-2-CARBOXAMIDES, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
BRPI0608216A2 (en) therapeutic agent for a tumor, method for treating a tumor, and use of a benzoyl compound, a prodrug thereof or a pharmaceutically acceptable salt thereof
ATE449082T1 (en) (3,4-DIHYDRO-QUINAZOLINE-2-YL)-(2-ARYLOXY-ETHYL) AMINE WITH ACTIVITY ON THE 5-HT RECEPTOR
CY1108366T1 (en) 7- (2- (4- (3-Trifluoromethyl-phenyl-1,2,3,6-tetrahydro-pyrid-1-yl) ethyl) benzosulfonate salt of isokinoline, isoform
UY27685A1 (en) INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE
AR043055A1 (en) DERIVATIVES OF 1- (4-BENZIL-PIPERAZIN-1-IL) -3- FENIL-PROPENONA
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
AR058405A1 (en) INHIBITING AMIDAS OF LEUCOTRENE A4 HIDROLASA
NO20082436L (en) Compounds with medical effects due to the interaction with glucocorticoid receptor